Ovarian Cancer Prevention in High-risk Women

被引：25
|
作者：
Temkin, Sarah M. [1 ]
Bergstrom, Jennifer [2 ]
Samimi, Goli [3 ]
Minasian, Lori [3 ]
机构：
[1] Virginia Commonwealth Univ, Dept Obstet & Gynecol, Richmond, VA USA
[2] Johns Hopkins Sch Med, Kelly Gynecol Oncol Serv, Baltimore, MD USA
[3] NCI, Div Canc Prevent, Bethesda, MD 20892 USA
来源：
CLINICAL OBSTETRICS AND GYNECOLOGY | 2017年 / 60卷 / 04期
关键词：
ovarian cancer prevention; BRCA; risk-reducing surgery; REDUCING SALPINGO-OOPHORECTOMY; BRCA2 MUTATION CARRIERS; QUALITY-OF-LIFE; TUBAL INTRAEPITHELIAL CARCINOMA; HEREDITARY BREAST; FALLOPIAN-TUBE; GYNECOLOGIC CANCERS; GERMLINE MUTATIONS; SEROUS CARCINOMA; BILATERAL OOPHORECTOMY;
D O I：
10.1097/GRF.0000000000000318
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
Ovarian carcinoma is the most lethal malignancy of the female genital tract. Population-based trials in the general population have not demonstrated that screening improves early detection or survival. Therefore, application of prevention strategies is vital to improving outcomes from this disease. Surgical prevention reduces risk and prophylactic risk-reducing salpingo-oophorectomy is the most effective means to prevent ovarian carcinoma in the high-risk patient although the risks do not outweigh the benefits in average risk patients. Other surgical and medical options have unknown or limited efficacy in the high-risk patient. In this review, we define the patient at high risk for ovarian cancer, discuss how to identify these women and weigh their available ovarian cancer prevention strategies.
引用
收藏
页码：738 / 757
页数：20
相关论文
共 50 条
  • [41] Fallopian Tube Lesions in Women at High Risk for Ovarian Cancer: A Multicenter Study
    Visvanathan, Kala
    Shaw, Patricia
    May, Betty J.
    Bahadirli-Talbott, Asli
    Kaushiva, Alpana
    Risch, Harvey
    Narod, Steven
    Wang, Tian-Li
    Parkash, Vinita
    Vang, Russell
    Levine, Douglas A.
    Soslow, Robert
    Kurman, Robert
    Shih, Ie-Ming
    CANCER PREVENTION RESEARCH, 2018, 11 (11) : 697 - 705
  • [42] Perioperative Management of Women Undergoing Risk-reducing Surgery for Hereditary Breast and Ovarian Cancer
    AlHilli, Mariam M.
    Al-Hilli, Zahraa
    JOURNAL OF MINIMALLY INVASIVE GYNECOLOGY, 2019, 26 (02) : 253 - 265
  • [43] Concerns and Expectations of Risk-Reducing Surgery in Women with Hereditary Breast and Ovarian Cancer Syndrome
    Modaffari, Paola
    Ponzone, Riccardo
    Ferrari, Alberta
    Cipullo, Isabella
    Liberale, Viola
    D'Alonzo, Marta
    Maggiorotto, Furio
    Biglia, Nicoletta
    JOURNAL OF CLINICAL MEDICINE, 2019, 8 (03):
  • [44] Pancreatic Cancer Screening among High-risk Individuals
    Turner, Kevin M.
    Patel, Sameer H.
    SURGICAL CLINICS OF NORTH AMERICA, 2024, 104 (05) : 951 - 964
  • [45] Options in Prophylactic Surgery to Prevent Ovarian Cancer in High-Risk Women: How New Hypotheses of Fallopian Tube Origin Influence Recommendations
    Casey L. Swanson
    Jamie N. Bakkum-Gamez
    Current Treatment Options in Oncology, 2016, 17
  • [46] Non-BRCA1/2 Variants Detected in a High-Risk Chilean Cohort With a History of Breast and/or Ovarian Cancer
    Adaniel, Christina
    Salinas, Francisca
    Manuel Donaire, Juan
    Eugenia Bravo, Maria
    Peralta, Octavio
    Paredes, Hernando
    Aliaga, Nuvia
    Sola, Antonio
    Neira, Pauline
    Behnke, Carolina
    Rodriguez, Tulio
    Torres, Soledad
    Lopez, Francisco
    Hurtado, Claudia
    JOURNAL OF GLOBAL ONCOLOGY, 2019, 5 : 1 - 14
  • [47] Prophylactic salpingectomy in premenopausal low-risk women for ovarian cancer: Primum non nocere
    Morelli, Michele
    Venturella, Roberta
    Mocciaro, Rita
    Di Cello, Annalisa
    Rania, Erika
    Lico, Daniela
    D'Alessandro, Pietro
    Zullo, Fulvio
    GYNECOLOGIC ONCOLOGY, 2013, 129 (03) : 448 - 451
  • [48] Flutamide and Biomarkers in Women at High Risk for Ovarian Cancer: Preclinical and Clinical Evidence
    Gruessner, Christine
    Gruessner, Angelika
    Glaser, Katherine
    AbuShahin, Nisreen
    Zhou, Yi
    Laughren, Cynthia
    Wright, Heather
    Pinkerton, Samantha
    Yi, Xiaofang
    Stoffer, Jha'nae
    Azodi, Masoud
    Zheng, Wenxin
    Chambers, Setsuko K.
    CANCER PREVENTION RESEARCH, 2014, 7 (09) : 896 - 905
  • [49] Age of uptake of early cancer detection facilities by low-risk and high-risk patients with familial breast and ovarian cancer
    Lux, MP
    Ackermann, S
    Bani, MR
    Nestle-Krämling, C
    Goecke, TO
    Niederacher, D
    Bodden-Heidrich, R
    Bender, HG
    Beckmann, MW
    Fasching, PA
    EUROPEAN JOURNAL OF CANCER PREVENTION, 2005, 14 (06) : 503 - 511
  • [50] Population-based genetic testing for Women's cancer prevention
    Evans, Olivia
    Gaba, Faiza
    Manchanda, Ranjit
    BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY, 2020, 65 : 139 - 153
12345